Prot #CBYL719XUS04T/NU 13B06: A Phase I Study of BYL719 and Trastuzumab-MCC-DM1 in HER2-Positive Metastatic Breast Cancer Patients with Progression on Prior Trastuzumab and Taxane-Based Therapy

  • Jain, Sarika (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/4/14 → 1/31/17

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CBYL719XUS04T/NU 13B06)